<DOC>
	<DOCNO>NCT01878188</DOCNO>
	<brief_summary>- Safety tolerability three regimen intravesically administer BC-819/PEI BCG ( number participant AEs , discontinuation due AEs ) - Recurrence treatment BC-819/PEI BCG - Approximately 18 patient superficial transitional cell carcinoma TCC ) bladder - After initial evaluation qualification , patient randomize one two treatment group , either alternate sequential</brief_summary>
	<brief_title>Pilot Study BC-819/PEI BCG Patients With Superficial Transitional Cell Bladder Carcinoma</brief_title>
	<detailed_description />
	<mesh_term>Carcinoma</mesh_term>
	<mesh_term>Carcinoma , Transitional Cell</mesh_term>
	<mesh_term>Urinary Bladder Neoplasms</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<mesh_term>BCG Vaccine</mesh_term>
	<criteria>1 . Patients superficial papillary transitional cell carcinoma bladder BCG clinically indicate . If CIS present , diagnosis need confirm biopsy prior start study . 2 . Males females 18 year old 3 . All papillary tumor must resect within 8 week prior start study therapy . 4 . ECOG performance status 2 less . 5 . Adequate hematologic function , demonstrate 1 . Hemoglobin 10 g/dL high 2 . ANC 1.5 x 109/L high 3 . Platelets high 100 x 109/L 6 . Adequate liver renal function demonstrate 1 . AST ALT 3.0 x ULN less 2 . Total bilirubin 1.5 x ULN less 3 . Creatinine 1.5 X ULN OR less , creatinine clearance &gt; 60 mL/min 7 . If fertile sexually active , must use adequate contraception 8 . Must able comply protocol requirement , include attendance require clinic visit . 9 . Patients must provide write informed consent . 1 . Patients candidate either partial total bladder resection , unless either medically contraindicate refuse surgery . 2 . Patients tumor diverticulum , prostatic urethra , cover ureteral orifice . 3 . Patients receive cytotoxic drug , systemic corticosteroid investigational drug indication within 4 week start protocol treatment . 4 . Patients receive intravesical therapy surgical resection within 8 week prior start protocol treatment . 5 . Patients receive radiation therapy bladder cancer time condition within 4 month prior start protocol treatment . 6 . Patients active infection , include urinary tract infection , whether viral , bacterial fungal require therapy . 7 . Patients receive coumadin . 8 . Patients discontinue past course BCG due toxicity . 9 . Patients urinary tract sign symptom recent urinary tract procedure manipulation , biopsy catheterization . 10 . Patients know HIV positive . 11 . Females pregnant breast feeding . 12 . Presence medical , psychological social condition situation may , investigator 's opinion , make difficult patient tolerate study medication comply study procedures requirement . This include limited active infection , poorly control diabetes , uncontrolled cardiac arrhythmia , angina pectoris , hypertension .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2014</verification_date>
</DOC>